About
HoneyBear Biosciences, Inc is a Taiwan-based biotech company developing next-generation antibody-drug conjugates using its proprietary CoNectar™ site-specific glycan conjugation platform to enable precise and dual-payload drug attachment for therapeutic antibodies.
Explore HoneyBear Biosciences, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.